CIFU', Adriana
 Distribuzione geografica
Continente #
NA - Nord America 1.505
EU - Europa 384
AS - Asia 184
AF - Africa 11
OC - Oceania 2
SA - Sud America 1
Totale 2.087
Nazione #
US - Stati Uniti d'America 1.501
IT - Italia 153
DE - Germania 49
UA - Ucraina 45
CN - Cina 44
TR - Turchia 38
VN - Vietnam 38
IN - India 33
IE - Irlanda 31
SE - Svezia 27
GB - Regno Unito 24
FR - Francia 23
SG - Singapore 16
BE - Belgio 13
IR - Iran 9
KE - Kenya 6
RO - Romania 6
EG - Egitto 5
CA - Canada 4
AU - Australia 2
CZ - Repubblica Ceca 2
ES - Italia 2
HK - Hong Kong 2
RS - Serbia 2
AM - Armenia 1
AT - Austria 1
CL - Cile 1
FI - Finlandia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JP - Giappone 1
KH - Cambogia 1
LV - Lettonia 1
NL - Olanda 1
PL - Polonia 1
Totale 2.087
Città #
Chandler 262
Fairfield 153
Woodbridge 109
Ann Arbor 91
Ashburn 81
Seattle 79
Dearborn 75
Wilmington 71
Houston 55
Cambridge 53
Udine 39
Dong Ket 38
Izmir 38
Princeton 32
Dublin 30
Jacksonville 30
Beijing 24
Redmond 24
Venezia 21
Singapore 15
Trieste 15
Brussels 13
Boardman 12
San Diego 12
Leawood 7
Norwalk 7
Ansbach 6
Augusta 6
Dallas 6
Nanjing 5
Ogden 5
Redwood City 5
San Mateo 5
Cagliari 4
Cairo 4
Cinisello Balsamo 4
Des Moines 4
Los Angeles 4
Milan 4
Pune 4
Tavagnacco 4
Brentino Belluno 3
Calvenzano 3
Falls Church 3
Grafing 3
Halle 3
Kashan 3
Monmouth Junction 3
Mumbai 3
New Delhi 3
Phoenix 3
Postioma 3
Verona 3
Belgrade 2
Brno 2
Chions 2
Codroipo 2
Fuzhou 2
Hefei 2
Hong Kong 2
Kunming 2
Monferrato 2
New York 2
Ottawa 2
Torre Del Greco 2
Wuhan 2
Amsterdam 1
Ardabil 1
Azor 1
Brisbane 1
Budapest 1
Chongqing 1
Como 1
Denver 1
Düsseldorf 1
Eugene 1
Frankfurt am Main 1
Hebei 1
Henderson 1
Hyderabad 1
Kish 1
London 1
Madrid 1
Mesagne 1
Miami 1
Montreal 1
Munich 1
Nanchang 1
Orlando 1
Paris 1
Pesaro 1
Phnom Penh 1
Riga 1
Rome 1
Ronchis 1
Sacramento 1
Santiago 1
Scafati 1
Sligo 1
Sydney 1
Totale 1.552
Nome #
Exploring the plasmatic platelet-activating factor acetylhydrolase activity in patients with anti-phospholipid antibodies 196
Characterization of the Proinflammatory Profile of Synovial Fluid-Derived Exosomes of Patients with Osteoarthritis 184
Pro inflammatory stimuli enhance the immunosuppressive functions of adipose mesenchymal stem cells-derived exosomes 160
Potential Role of Exosomes in Countering Vedolizumab-Based Therapy in IBD Patients 135
ADMA as a possible marker of endothelial damage. A study in young asymptomatic patients with cerebral small vessel disease. 132
Anti-β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies exert similar pro-thrombotic effects in peripheral blood monocytes and endothelial cells 118
Pharmacogenetic Determinants of Response to Infliximab in Pediatric Inflammatory Bowel Disease. 74
Clinical applications of microenvironment-controlled immunosuppressive properties of mesenchymal stem cells-derived exosomes: a review 70
Toll-like Receptor-4 Activation Boosts the Immunosuppressive Properties of Tumor Cells-derived Exosomes 67
To investigate in vitro the pathogenic mechanism of anti-PS/PT antibodies to better define their role in the diagnosis of APS syndrome 66
The role of tumor-derived exosomes in cancer immune evasion mediated by toll-like receptor 4 activation 64
Characterization of the Proinflammatory Profile of Synovial Fluid-Derived Exosomes of Patients with Gonarthrosis. 64
Asymmetrical Dimethylarginine (ADMA) In Asympomatic Cerebral Small Vessel Disease. 63
Comparison between Anti-β2Glycoprotein I Antibody and Anti-Phosphatidylserine/Prothrombin Antibody Biological Effects on Peripheral Blood Monocytes 60
Do circulating exosomes interfere with vedolizumab efficacy in IBD patients? 58
Characterization of Parotid Gland Epithelial Cell Primary Cultures from Patients Affected by Sjogren’s Syndrome 53
Is the Asymmetric Dimethylarginine (ADMA) the Possible Molecule Driving Endothelial Damage in Young Asymptomatic Patients with Cerebral Small Vessel Disease? 51
The Effect of Osteoarthritic Synovial Fluid on Immunomodulatory Properties of Adipose Mesenchymal Stem Cells. 47
Elevated Plasma Platelet-Activating Factor Acetylhydrolase Activity is Significantly Associated with High Risk Anti-Phospholipid Antibody Antigenic Specificities . 47
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study 46
The immunomodulatory properties of adipose mesenchymal stem cell-derived exosomes are induced by inflammatory cytokines . 45
Anti-phosphatidylserine/prothrombin Autoantibodies Significantly Improve The Laboratory Diagnostic Process Of Anti-phospholipids Antibody Syndrome. 45
The Effect of Serum of Cerebral Small Vessel Disease Patients on Brain Endothelial Cells 45
Toll-like Receptor-4 Activation Improves the Immunosuppressive Properties of Cancer Cells-Derived Exosomes. 40
Circulating exosomes express α4β7 integrin and compete with CD4+ T cells for the binding to Vedolizumab 40
The Exposure to Osteoarthritic Synovial Fluid Enhances the Immunomodulatory Profile of Adipose Mesenchymal Stem Cell Secretome 39
Preliminary Evaluation of a new immunofluorescence mosaic assay for inflammatory bowel disease diagnosis: a pilot study in Udine 35
A large biomarker investigation in young asymptomatic patients with cerebral vessel disease identified ADMA as a possible key molecule driving endothelial damage. 34
Comparison between anti-β2 Glycoprotein I antibody and anti-phosphatidyserine/prothrombin antibody pro-thrombotic effects on peripheral blood monocytes and endothelial cells . 32
Validation of a One-Step Reverse Transcription-Droplet Digital PCR (RT-ddPCR) Approach to Detect and Quantify SARS-CoV-2 RNA in Nasopharyngeal Swabs 31
Tumor Exosomes Mediate the Horizontal Transfer of DNA Gene Mutation 30
The influence of a stressful microenvironment on tumor exosomes: a focus on the DNA cargo 30
Brain Endothelial Cells Activate Neuroinflammatory Pathways in Response to Early Cerebral Small Vessel Disease (CSVD) Patients’ Plasma 11
Totale 2.212
Categoria #
all - tutte 8.697
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.697


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020451 0 17 15 57 47 91 49 42 41 58 16 18
2020/2021485 11 114 9 45 24 26 20 43 66 24 50 53
2021/2022310 12 25 13 21 3 11 15 19 8 41 104 38
2022/2023504 40 51 2 92 38 104 3 61 69 2 23 19
2023/2024118 16 12 5 5 12 17 2 11 13 8 4 13
2024/202524 12 12 0 0 0 0 0 0 0 0 0 0
Totale 2.212